Working… Menu

Exploratory Study of BO-112 in Adult Patients With Aggressive Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02828098
Recruitment Status : Terminated
First Posted : July 11, 2016
Last Update Posted : July 31, 2020
Pivotal S.L.
Information provided by (Responsible Party):
Highlight Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2020
Actual Study Completion Date : July 2020